Immune Response Study: Posdinemab

We are examining how the immune system reacts in participants who received Posdinemab. This research aims to improve our understanding of its effects on the immune system.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Pellegrin Hospital
Neurology
Bordeaux, France
Centre Hospitalier Universitaire De Lille
Neurology
Épône, France
Brain Research Center Den Bosch B.V.
Brain Research Center Den Bosch / Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands

Sponsor: Janssen Cilag International
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.